Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 01.06.2026 1 Am J Gastroenterol 1 Ann Surg 8 Anticancer Res 8 BMC Cancer 1 BMC Surg 1 Dis Esophagus 4 Head Neck 1 Int J Radiat Oncol Biol Phys 10 Oral Oncol 5 Otolaryngol Head Neck Surg 5 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. MEN X, Wang Y, Zhao Y, Zhang H, et al
   Endoscopy-based Deep Learning Algorithms versus Endoscopists in Early Esophageal Squamous Cell Carcinoma Detection: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2026 May 26. doi: 10.14309/ajg.0000000000004067.
   PubMed         Abstract available
   
   

   
   Ann Surg

2. GANGARAM PANDAY SSG, In 't Veld D, Mostert B, Doukas M, et al
   Pathological Outcomes After Uncertain Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
   Ann Surg. 2026 May 25. doi: 10.1097/SLA.0000000000007101.
   PubMed         Abstract available
   
   

   
   Anticancer Res

3. LIN CY, Lin YS, Fang HY, Wang CC, et al
   Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study.
   Anticancer Res. 2026;46:3493-3508.
   PubMed         Abstract available
   
   
4. CHENG-KAI S, Liu CC, Li Y
   Scutellarein Induces Apoptosis in SCC-25 Oral Squamous Cell Carcinoma Cells Through Suppression of the PI3K/Akt Pathway.
   Anticancer Res. 2026;46:3219-3229.
   PubMed         Abstract available
   
   
5. YANG CH, Li Y, Tao CC, Lan YY, et al
   Ginsenoside Rh4 Induces Apoptosis Through ROS-Mediated Fas Signaling in Human Nasopharyngeal Carcinoma NPC/HK1 Cells.
   Anticancer Res. 2026;46:3179-3189.
   PubMed         Abstract available
   
   
6. CHAN FC, Lin ZY, Chang KP, Su WH, et al
   Genome-wide Analysis Highlights rs4671908 and rs2238431 as Predictors of Survival in Nasopharyngeal Carcinoma.
   Anticancer Res. 2026;46:3099-3115.
   PubMed         Abstract available
   
   
7. NISHIDA A, Nakashima R, Hiraoka S, Nakajima A, et al
   Clinical Outcomes and Failure Patterns After Postoperative IMRT for Olfactory Neuroblastoma: Late Cervical Nodal Relapse.
   Anticancer Res. 2026;46:3441-3451.
   PubMed         Abstract available
   
   
8. SHIH LC, Hsu CL, Yang YC, Chen JC, et al
   MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers.
   Anticancer Res. 2026;46:3205-3217.
   PubMed         Abstract available
   
   
9. SUZUKI H, Hagiwara S, Beppu S, Kobayashi Y, et al
   Unexpected Modifications to Surgical Plans in Computer-assisted Mandibulectomy With Fibula Free-flap Reconstruction: A Five-case Series.
   Anticancer Res. 2026;46:3509-3515.
   PubMed         Abstract available
   
   
10. HIHARA K, Okamoto I, Tokashiki K, Ueda Y, et al
    Pembrolizumab and Quality of Life in Recurrent or Metastatic Head and Neck Cancer.
    Anticancer Res. 2026;46:3343-3350.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. UHL B, Eggert D, Smiljanov B, von Thun Und Hohenstein K, et al
    Targeting EpCAM expression via near-infrared fluorescent antibodies enables microscopic delineation of primary and recurrent HNSCC.
    BMC Cancer. 2026;26:671.
    PubMed         Abstract available
    
    
12. YANG Y, Luo Y, Wu T, Huang G, et al
    Effect of body mass index and age on the prognosis of non-metastatic nasopharyngeal carcinoma.
    BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16276.
    PubMed         Abstract available
    
    
13. MEHTA V, Fraile JF, Mathur A, Bhadania M, et al
    Effects of metformin on head and neck cancer: an umbrella review.
    BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16057.
    PubMed         Abstract available
    
    
14. PAN D, Xu Y, Tao Y, Huang F, et al
    A pilot study assessing the feasibility of contrast-enhanced ultrasound for triaging fine-needle aspiration in lateral cervical lymph nodes of papillary thyroid carcinoma.
    BMC Cancer. 2026 May 28. doi: 10.1186/s12885-026-16243.
    PubMed         Abstract available
    
    
15. DUAN C, Yu P, Wei X, Zhong J, et al
    The role of age and antibodies in central regional lymph node metastases of papillary thyroid carcinoma combined with hashimoto's thyroiditis.
    BMC Cancer. 2026 May 27. doi: 10.1186/s12885-026-16229.
    PubMed         Abstract available
    
    
16. SUN Z, Lin D, Liu Y, Li S, et al
    Serum amyloid A kinetics predicts outcomes to PD-1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.
    BMC Cancer. 2026 May 26. doi: 10.1186/s12885-026-16220.
    PubMed         Abstract available
    
    
17. KOROGLU EY, Evranos Ogmen B, Deniz MS, Saylam B, et al
    Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study.
    BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16218.
    PubMed         Abstract available
    
    
18. SOLEIMANI SARDOU S, Rezvaninejad R, Rezvaninejad FS, Nekouei AH, et al
    Artificial intelligence for oral cancer diagnosis: a systematic review and meta-analysis of image-based and non-imaging models.
    BMC Cancer. 2026 May 25. doi: 10.1186/s12885-026-16154.
    PubMed         Abstract available
    
    

    
    BMC Surg

19. FRIES F, Thaeren J, Greschus S, Muschler E, et al
    Preoperative imaging strategies to optimize surgical treatment in primary hyperparathyroidism (pHPT).
    BMC Surg. 2026;26:340.
    PubMed         Abstract available
    
    

    
    Dis Esophagus

20. ALHAYO S, Seabourne E, Hall L, Shepherdson M, et al
    Real-world outcomes of FLOT versus Chemoradiotherapy for Esophageal, Type I and II Junctional Tumors: A Bi-Center International Study.
    Dis Esophagus. 2026;39:doag052.
    PubMed         Abstract available
    
    

    
    Head Neck

21. TALWAR A, Ben-Levy O, Sriram N, Samant S, et al
    The Role of Multicancer Early Detection Tests in Head and Neck Squamous Cell Carcinoma: A Case Series.
    Head Neck. 2026 May 28. doi: 10.1002/hed.70337.
    PubMed         Abstract available
    
    
22. STOEL GW, Olazagasti C
    Beyond Low-Dose CT: Rethinking Lung Cancer Screening in Survivors of Head and Neck Cancer.
    Head Neck. 2026 May 26. doi: 10.1002/hed.70331.
    PubMed        
    
    
23. FERREIRA MLV, Oliveira ACR, Cardoso FDS, Lessa AFN, et al
    Epidemiological and Clinical Profile of Young Patients With Head and Neck Cancer: A Retrospective Analysis.
    Head Neck. 2026 May 24. doi: 10.1002/hed.70327.
    PubMed         Abstract available
    
    
24. GILL J, Virk J, Azam M, Fekrmandi F, et al
    Association of Absolute Neutrophil Count With Outcomes in Patients With Head and Neck Cancer Receiving Definitive Chemoradiation.
    Head Neck. 2026 May 22. doi: 10.1002/hed.70324.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

25. PETIT C, Phan J, Ng SP, Filion E, et al
    Defining the Role of SABR in Head and Neck Cancer: Results from a Multi-institutional Delphi Consensus.
    Int J Radiat Oncol Biol Phys. 2026 May 22:S0360-3016(26)00760.
    PubMed         Abstract available
    
    

    
    Oral Oncol

26. JOSEPH ST, Padmanabhan S, George A, Gopal KR, et al
    Dissociating recurrence risk from mortality: a 10 year analysis challenging the independent prognostic value of depth of invasion in oral cavity squamous cell carcinoma.
    Oral Oncol. 2026;178:108001.
    PubMed         Abstract available
    
    
27. ROOF SA, Sicard RM, Chennareddy S, Ahn S, et al
    Post-treatment circulating tumor DNA clinical features, prognosis in HPV-positive oropharynx cancer.
    Oral Oncol. 2026;178:108003.
    PubMed         Abstract available
    
    
28. YILDIZ I, Tasci ES, Yucel S
    HPV-positive oropharyngeal squamous cell carcinoma: risk-adapted treatment strategies and biomarker-guided individualization.
    Oral Oncol. 2026;178:108005.
    PubMed         Abstract available
    
    
29. VILLA A, Peterson DE, Lingen MW, Pearson A, et al
    Artificial intelligence model predicts malignant transformation of oral leukoplakia and optimizes interventions.
    Oral Oncol. 2026;178:107982.
    PubMed         Abstract available
    
    
30. KABONGO CM, Bowman T, Tracy J, Soneru C, et al
    Changing epidemiology of sinonasal cancer in the United States.
    Oral Oncol. 2026;178:107996.
    PubMed         Abstract available
    
    
31. TOMASONI M, Lorini L, Ferrari M, Missale F, et al
    Prognostic factors and survival after recurrence in major salivary gland carcinomas: a multicenter study.
    Oral Oncol. 2026;178:107979.
    PubMed         Abstract available
    
    
32. BAKHTIAR M, Al-Inaya Y, Das D, Margalit DN, et al
    Clearance of circulating HPV DNA during chemoradiation using a next-generation sequencing liquid biopsy.
    Oral Oncol. 2026;178:107984.
    PubMed         Abstract available
    
    
33. LI C, Li J, Jin T, Wang Z, et al
    Quantitative autofluorescence imaging for predicting malignant transformation of oral leukoplakia: a long-term follow-up study.
    Oral Oncol. 2026;178:107983.
    PubMed         Abstract available
    
    
34. WILLIAMSON A, Burton S, Rajan Z, Kwong E, et al
    Salvage surgery for residual and recurrent head and neck squamous cell carcinoma (RESCUE): An IReC multicentre consecutive cohort study.
    Oral Oncol. 2026;179:107997.
    PubMed         Abstract available
    
    
35. STAIBANO P, Au M, Ganly I, de Almeida JR, et al
    Elective neck dissection and adjuvant therapy in N0 major salivary gland cancer: An analysis of the SEER cancer database.
    Oral Oncol. 2026;179:108015.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

36. ZARRELLA D, Chitnis O, Kim HE, Wrozek T, et al
    Long-Term Health-Related Quality of Life in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
    Otolaryngol Head Neck Surg. 2026;174:1421-1433.
    PubMed         Abstract available
    
    
37. SRIDHAR S, Larson DP, Swain BB, Suh H, et al
    Association of Preoperative Depression and Clinical Outcomes After Head and Neck Free Flap Reconstruction.
    Otolaryngol Head Neck Surg. 2026;174:1476-1483.
    PubMed         Abstract available
    
    
38. YANG KS, Lin YT, Chuang HC, Chien CY, et al
    Margin to Depth of Invasion Ratio on Oncologic Outcomes in Node-Negative Oral Tongue Cancer.
    Otolaryngol Head Neck Surg. 2026;174:1524-1532.
    PubMed         Abstract available
    
    
39. PUENTE-VEREZ M, Martin-Gonzalez R, Pedregal-Mallo D, Garcia-Pedrero JM, et al
    Prognostic Utility of Hematological Inflammatory Markers in Stratifying Cancer Risk in Laryngeal Premalignant Lesions.
    Otolaryngol Head Neck Surg. 2026;174:1562-1571.
    PubMed         Abstract available
    
    
40. BOSCOLO-RIZZO P, Giudici F, Polesel J, Tagliabue M, et al
    Recurrences and Survival in Oropharyngeal Squamous Cell Carcinoma According to p16 Status and Extranodal Extension.
    Otolaryngol Head Neck Surg. 2026;174:1541-1551.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

41. LOOMAN EL, van Zon-Meijer TWH, Ludwig R, Perez Haas Y, et al
    Patterns of lymphatic spread in laryngeal squamous cell carcinoma and personalization of the elective clinical target volume.
    Radiother Oncol. 2026;219:111491.
    PubMed         Abstract available
    
    
42. MAY L, Baeza-Ortega JA, Hussein M, Porter S, et al
    It's not your device, it's how you use it - Sensitivity and specificity of PSQA devices in the SEAFARER head and neck study.
    Radiother Oncol. 2026;219:111493.
    PubMed         Abstract available
    
    
43. DAVEY A, Chen Davies LS, Pan S, Krommenhoek KB, et al
    Systematic review of facial deformation following paediatric head and neck radiation therapy: A call for standardised outcome assessment and dose-response evidence.
    Radiother Oncol. 2026;219:111448.
    PubMed         Abstract available
    
    
44. LIN JB, Chen JC, Weng NH, Jan YT, et al
    Explainable machine learning to predict muscle loss during radiotherapy for oral cavity cancer.
    Radiother Oncol. 2026;219:111521.
    PubMed         Abstract available
    
    
45. CHIU K, Gupta A, Ashraf A, Chowdhury A, et al
    A sinGle-arm phase II study to assess efficacy, tOxicity, and quAlity of life following 27Gy in 6 fractions palliative intensity modulated radiotherapy with early integration of palliative care (GOAL27-6).
    Radiother Oncol. 2026;219:111524.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum